Mangold Insight Investor Breakfast
Cyxone is making progress on our groundbreaking early-stage treatments for Rheumatoid Arthritis, Multiple Sclerosis and Covid-19. On 7 April, 2021 between 10.20 and 10.40 CEO Tara Heitner will present the latest updates at the online event Mangold Insight Investor Breakfast.
Follow the presentation live at https://insight.mangold.se. And to reach out to our CEO to find out more about investing, partnering or for more information, contact her at email@example.com.